Description

LIVASTEP-M Tablet is an advanced anti-allergic formulation combining Levocetirizine and Montelukast, designed to provide comprehensive and long-lasting relief from allergic rhinitis and related respiratory allergic conditions. This dual-action therapy effectively controls both early and late-phase allergic responses, making it a preferred choice among healthcare professionals. Levocetirizine, a third-generation antihistamine, works by selectively blocking H1 histamine receptors, thereby relieving symptoms such as sneezing, runny nose, nasal congestion, watery eyes, itching, and skin irritation with minimal sedation. Montelukast, a leukotriene receptor antagonist, helps reduce airway inflammation, nasal blockage, and bronchial hypersensitivity, offering extended control over allergic symptoms, especially during night-time and chronic conditions. LIVASTEP-M Tablet is highly effective in the management of seasonal and perennial allergic rhinitis, dust and pollen allergy, allergic sinusitis, and allergy-associated asthma symptoms. The once-daily dosing ensures consistent symptom relief, improved breathing comfort, and enhanced quality of life for patients. The combination therapy addresses the root cause of allergic inflammation while ensuring excellent tolerability and patient compliance. LIVASTEP-M is suitable for long-term use under medical supervision and is widely prescribed in ENT and respiratory allergy management. Marketed by Varmed Pharma Pvt Ltd, a trusted pharmaceutical organization recognized as the Best PCD Pharma Franchise Company, LIVASTEP-M Tablet is a high-demand anti-allergy product with strong repeat prescriptions, making it an excellent offering under PCD Pharma Franchise distribution across India.